Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ·Healthcare·Biotechnology
$0.53
—
Mkt Cap $6.85M
No analyst coverage available
We don't have analyst ratings or price target data for Reviva Pharmaceuticals Holdings, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.